Ntethelelo Sibiya
Alina Kurylowicz
Andile Khathi- 1Pharmacology Division, Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa
- 2Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
- 3School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
Editorial on the Research Topic
Prediabetes - early interventions and prevention in insulin resistance
Prediabetes is regarded as a state of intermediate hyperglycaemia that exists between normoglycaemia and the onset of type 2 diabetes mellitus (T2DM). This condition is characterized by impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and elevated glycated hemoglobin concentrations without reaching the threshold for a diagnosis of T2DM (1, 2). Due to the asymptomatic nature of the condition, prediabetes is generally regarded as under-diagnosed (1). Recent estimates show that the prevalence of prediabetes was at 280 million in 2013, it is expected to increase to 398 million by the year 2030 (3). The increase prevalence of this condition has been directly correlated to the increased consumption of high-calorie diets consisting of refined carbohydrates and saturated fats as well as sedentary lifestyles in modernized and urbanized areas (4). Other risk factors associated with prediabetes include age, obesity and other pathological conditions that can result into a state insulin resistance (4). Using a diet-induced animal model of prediabetes, recent studies have shown that the complications often observed in overt T2DM may begin during the prediabetic state (5–9). Using the same model, a study has demonstrated that prediabetes is a risk factor for developing preeclampsia (Ludidi et al.). In another recently published study using the same model, prediabetes was reported to result in higher fibrinolysis and endothelial dysfunction when compared to non-prediabetic animals (Gumede and Khathi). With several studies showing that prediabetes is reversible, this condition has since emerged as a potential avenue for dietary and pharmacological intervention to prevent the onset of T2DM (10).
The management of overt T2DM and the associated complications places a huge financial burden on health care systems globally as various pharmacological agents that range from, but not limited to, anti-hyperglycaemics, cholesterol lowering agents, anti-coagulants and antihypertensives are often required. Therefore, the prevention and management of prediabetes perhaps through dietary intervention and natural products could be paramount in alleviating the costs associated with overt T2DM. A recently completed clinical trial (NCT03222791) demonstrated a significant change in metabolic profile and gut microbiota composition after a six-month dietary intervention through a personalized postprandial glucose-targeting diet or the standard of care Mediterranean diet (11). This trial further highlighted the impact of dietary intervention on the improvement of microbiota, perhaps influencing better metabolic outcomes. Without trivializing the effectiveness of dietary intervention, however it requires strict adherence and high motivation, hence probiotic as an alternative therapeutic intervention could serve a similar purpose interms of improving gut microbiota (11). For further understanding, a randomized clinical trial protocol aiming to determine the effectiveness of healthy diet in early pregnancy stages in preventing gestational diabetes mellitus has also been registered (Bernier et al.). This Research Topic briefly consolidates some cutting-edge research on recent strides focused on the prevention and management of prediabetes through dietary interventions and natural products.
A conflicting evidence has been presented on the effect of dietary fats including monosaturated (MUFA) and polysaturated fats (PUFA), thus necessitating larger scale populations studies. A recently published study by Jiang et al. based on a nationally representative population sample of the United States found that dietary MUFA and PUFA (18:2 and 18:3) intake to be associated with a decreased incidence of prediabetes and T2DM especially in young adults. The plant-based diet has also gained momentum in the prevention and managing prediabetes. Although there is evidence of plant-based diet benefits, however there are some inconsistencies. For these reasons more epidemiological looking at the association between active ingredient, i.e., flavonoids from plant-based diets and the risk of prediabetes are of paramount importance. A recently published study from a completed large scale survey suggests that higher intake of flavonoids is associated with a decrease in the risk of developing prediabetes which also correlates with previous data that showed beneficial effects of flavonoids in overt T2DM (Zhou et al.). Flavonoids are the category of bioactive compounds, abundantly present in several plant-originated foods, including fruits, vegetables, herbs, and any other edible plant parts. In quest of further understanding the beneficial role of natural compounds of plant-origin, Chen et al. aimed to consolidate evidence of various natural compounds effect on prediabetes and associated mechanisms of action. In a recently published review paper, natural compound classes such as phenolic compounds, flavonoids, terpenoids, alkaloids, glycosides, quinones, lactones, and saponins, natural compounds showed varying biological and pharmacological activities for prediabetes (Chen et al.). The evidence above, illuminates the beneficial effect of dietary intervention and natural compounds on the prevention and management of prediabetes. To expedite and validate our understanding on the effectiveness of diet-based interventions, clinical trials are however required. Another diet-based intervention which is gaining momentum in glycaemic control is intermittent fasting as it has been shown to show therapeutic effects. Recent studies have reported on several intermittent fasting strategies that include twice-per-week fasting, fasting-mimicking diets, time-restricted eating, and periodic fasting (12). A meta-analysis conducted by Xiaoyu et al. suggests that the twice per week fasting strategy affords better glycaemic control when compared with other strategies in the same category. Literature evidence demonstrates intermittent energy restriction to be efficacious in preventing and managing both prediabetes and T2DM while further showing protective benefits that extend beyond glycaemic control (13). Interestingly, a recent meta-analysis suggests that intermittent energy restriction is slightly more effective than the continuous counterpart, however, long term studies are still necessary (14). Considering that this is a relatively emerging field of study, more clinical studies and refinements are required to shape guidelines and policy development toward implementing this strategy in the prevention and management of prediabetes. Taken together, we envisage that the collection of works in this Research Topic will hopefully inspire and accelerate preventative and therapeutic strategies toward the management and possible treatment of prediabetes.
Author contributions
NS: Conceptualization, Validation, Writing – original draft, Writing – review & editing. AKu: Conceptualization, Validation, Writing – review & editing. AKh: Conceptualization, Validation, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Edwards CM, Cusi K. Prediabetes: a worldwide epidemic. Endocrinol Metab Clin. (2016) 45:751–64. doi: 10.1016/j.ecl.2016.06.007
2. Huang D, Refaat M, Mohammedi K, Jayyousi A, Al Suwaidi J, Abi Khalil C, et al. Macrovascular complications in patients with diabetes and prediabetes. BioMed Res Int. (2017) 2017:7839101. doi: 10.1155/2017/7839101
3. Aguirre F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T, et al. IDF Diabetes Atlas, 6th Edn. Brussels: International Diabetes Federation (2013).
4. Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes. (2012) 19:93–6. doi: 10.1097/MED.0b013e328350583a
5. Dimba NR, Mzimela N, Ngubane PS, Khathi A. Investigating the association between diet-induced “leaky gut” and the development of prediabetes. Exp Clin Endocrinol Diabetes. (2023) 131:569–76. doi: 10.1055/a-2181-6664
6. Dlamini M, Khathi A. Investigating the effects of diet-induced prediabetes on skeletal muscle strength in male Sprague Dawley rats. Int J Mol Sci. (2024) 25:4076. doi: 10.3390/ijms25074076
7. Mkhize BC, Mosili P, Ngubane PS, Sibiya NH, Khathi A. Diet-induced prediabetes: effects on the activity of the renin–angiotensin–aldosterone system in selected organs. J Diabetes Investig. (2022) 13:768–80. doi: 10.1111/jdi.13690
8. Mosili P, Mkhize BC, Ngubane P, Sibiya N, Khathi A. The dysregulation of the hypothalamic-pituitary-adrenal axis in diet-induced prediabetic male Sprague Dawley rats. Nutr Metab. (2020) 17:104. doi: 10.1186/s12986-020-00532-1
9. Mzimela NC, Ngubane PS, Khathi A. The changes in immune cells during the progression of prediabetes to type 2 diabetes in a high-fat high-carbohydrate diet-induced pre-diabetic rat model. Autoimmunity. (2019) 52:27–36. doi: 10.1080/08916934.2019.1575820
10. Tabák AG, Herder C, Kivimäki M. Prediabetes: a high-risk state for developing diabetes. Lancet. (2012) 379:2279–90. doi: 10.1016/S0140-6736(12)60283-9
11. Shoer S, Shilo S, Godneva A, Ben-Yacov O, Rein M, Wolf BC, et al. Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines. Nat Commun. (2023) 14:5384. doi: 10.1038/s41467-023-41042-x
12. van den Burg EL, Van Peet PG, Schoonakker MP, van de Haar DE, Numans ME, Pijl H, et al. Metabolic impact of intermittent energy restriction and periodic fasting in patients with type 2 diabetes: a systematic review. Nutr Rev. (2023) 81:1329–50. doi: 10.1093/nutrit/nuad015
13. Cioffi I, Evangelista A, Ponzo V, Ciccone G, Soldati L, Santarpia L, et al. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. J Transl Med. (2018) 16:1–5. doi: 10.1186/s12967-018-1748-4
Keywords: prediabetes, early interventions, prevention, insulin resistance, diet
Citation: Sibiya N, Kurylowicz A and Khathi A (2024) Editorial: Prediabetes - early interventions and prevention in insulin resistance. Front. Nutr. 11:1434569. doi: 10.3389/fnut.2024.1434569
Received: 18 May 2024; Accepted: 27 May 2024;
Published: 03 June 2024.
Edited and reviewed by: Ellen E. Blaak, Maastricht University, Netherlands
Copyright © 2024 Sibiya, Kurylowicz and Khathi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ntethelelo Sibiya, n.sibiya@ru.ac.za